Edition:
United Kingdom

miRagen Therapeutics Inc (MGEN.OQ)

MGEN.OQ on NASDAQ Stock Exchange Capital Market

5.64USD
24 Sep 2018
Change (% chg)

$0.02 (+0.36%)
Prev Close
$5.62
Open
$5.60
Day's High
$5.67
Day's Low
$5.39
Volume
45,448
Avg. Vol
42,278
52-wk High
$10.68
52-wk Low
$5.01

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 2.18 -0.288
Mar '18 4.78 -0.176
FY 2017 Dec '17 1.19 -0.286
Sep '17 1.63 -0.270
Jun '17 0.72 -0.342
Mar '17 0.46 -0.604
FY 2016 Dec '16 0.51 -9.194
Sep '16 0.94 -6.924
Jun '16 1.12 -5.877
Mar '16 0.92 -5.583
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 3 1.89 2.20 1.30 0.72
Quarter Ending Dec-18 3 2.04 3.18 1.23 0.72
Year Ending Dec-18 4 9.93 12.33 7.00 0.96
Year Ending Dec-19 4 5.46 10.73 0.00 0.96
Earnings (per share)
Quarter Ending Sep-18 4 -0.32 -0.26 -0.38 -0.44
Quarter Ending Dec-18 4 -0.33 -0.28 -0.38 -0.46
Year Ending Dec-18 4 -1.12 -1.01 -1.20 -1.66
Year Ending Dec-19 4 -1.58 -1.33 -2.00 -1.80
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.68 32.76
P/E High - Last 5 Yrs. -- 300.70 45.44
P/E Low - Last 5 Yrs. -- 92.08 24.26
Beta 1.97 0.93 0.89
Price to Sales (TTM) 71.79 114.98 5.74
Price to Book (MRQ) 4.91 15.51 5.00
Price to Tangible Book (MRQ) 4.91 14.62 6.57
Price to Cash Flow (TTM) -- 72.88 23.29
% Owned Institutions 44.73 14.70 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.36 1.51
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.72 5.22
Payout Ratio(TTM) -- 16.50 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -35.61 411.54 8.01
Sales (TTM) vs TTM 1 Yr. Ago -11.50 80.36 5.64
Sales - 5 Yr. Growth Rate 11.74 32.26 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago 94.19 29.14 20.61
EPS (TTM) vs TTM 1 Yr. Ago 48.38 -- --
EPS - 5 Yr. Growth Rate -- 39.84 10.66
Capital Spending - 5 Yr. Growth Rate -64.33 40.42 15.34

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.91 2.22
Current Ratio (MRQ) 7.44 5.46 3.03
LT Debt to Equity (MRQ) 4.53 35.27 12.51
Total Debt to Equity (MRQ) 9.31 37.09 16.85
Interest Coverage (TTM) -59.71 -102.34 32.72

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 12.53 39.18 54.37
Gross Margin - 5 Yr. Avg. 25.55 50.58 52.16
EBITD Margin (TTM) -654.94 -- --
EBITD - 5 Yr. Avg -161.55 -600.62 10.68
Operating Margin (TTM) -766.34 -759.68 4.33
Operating Margin - 5 Yr. Avg. -184.26 -621.65 6.11
Pre-Tax Margin (TTM) -768.18 -733.53 5.18
Pre-Tax Margin - 5 Yr. Avg. -209.71 -627.35 6.51
Net Profit Margin (TTM) -768.18 -734.90 1.48
Net Profit Margin - 5 Yr. Avg. -209.71 -630.40 2.78
Effective Tax Rate (TTM) -- 23.33 23.11
Effective Tax Rate - 5 Yr. Avg. -- 18.66 23.97

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 23,229,030 860,305,024
Net Income/Employee (TTM) -- 3,144,146 101,198,978
Receivable Turnover (TTM) 4.72 20.89 5.87
Inventory Turnover (TTM) -- 2.46 3.41
Asset Turnover (TTM) 0.10 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -73.48 -0.15 11.13
Return on Assets - 5 Yr. Avg. -95.81 3.51 12.40
Return on Investment (TTM) -87.08 1.79 14.61
Return on Investment - 5 Yr. Avg. -- 2.56 16.13
Return on Equity (TTM) -90.87 3.28 16.33
Return on Equity - 5 Yr. Avg. -- 3.43 17.39
  1 Year 3 Year 5 Year
Sales % 31.48 -8.22 11.74
EPS (TTM) % 16.33 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for miRagen Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 3.40 -0.17 99 52
13 Week -27.55 -31.08 25 66
26 Week -23.99 -29.77 52 80
52 Week 23.64 4.80 99 50
YTD 88.42 65.47 99 61
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 54.95%
# of Holders: 89
Total Shares Held: 16,813,686
3 Mo. Net Change: 1,286,340
# New Positions: 12
# Closed Positions: 14
# Increased Positions: 49
# Reduced Positions: 26
# Net Buyers: 23
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.